“…CYP has also been associated with gonadal toxicity in male and female survivors of adult or childhood cancers (Kenney, Laufer, Grant, Grier, & Diller, 2001;Thomson et al, 2002); and patients treated for noncancer related pathologies like rheumatic diseases (Dooley & Nair, 2008;Silva, Bonfa, & Ostensen, 2010), myasthenia gravis and lupus glomerulonephritis (Slater, Liang, McCune, Christman, & Laufer, 1999;Wetzels, 2004). CYPinduced gonadal toxicity in humans (Dooley & Nair, 2008;Wetzels, 2004) and rodents (Çeribaşi, Türk, Sönmez, Sakin, & Ateşşahin, 2010;El Tawab, Shahin, & AbdelMohsen, 2014;Kim et al, 2013) is associated with oligospermia, azoospermia, alterations in gonadotrophin, alterations in testosterone levels/oxidative stress parameters and testicular tissue toxicity. CYP disrupts cell growth, differentiation and function, mainly by cross-linking DNA strands (Vernet, Aitken, & Drevet, 2004); and there are suggestions that CYP (either alone, or in combination with other agents) damages the germinal epithelium (Ginsberg, 2012).…”